All News

The FDA has approved, under Priority Review, GlaxoSmithKline (GSK)’s tafenoquine (Krintafel), which is the first single-dose medicine for the prevention of Plasmodium vivax (P vivax) malaria relapse in patients over the age of 16 years who are receiving antimalarial therapy.

Study establishes increased risk of all-site cancer for both men and women with diabetes, but the excess risk of cancer is greater for women.

A recent systematic review and meta-analysis found that men with advanced cancers respond better than women to treatment with anti-PD-1 or anti-CTLA-4 immune checkpoint inhibitors.

Taking advantage of cost-effective generic medications can improve access to hepatitis B treatment, especially in countries with a high disease burden.

Many clinicians have been preparing for USP for a long time and are well on their way to compliance.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Growing evidence suggests that integrating clinical pharmacy specialists into medical care teams that focus on diabetes improves glycemic control, and leads to better clinical outcomes in primary care settings.

A new research study, published in JAMA Cardiology, aimed to further confirm a previous correlation between asthma and atrial fibrillation (AF) and to determine if the degree of asthma control affected the risk of developing AF.

The FDA on Friday approved Pfizer's filgrastim-aafi, a filgrastim biosimilar to Amgen's Neupogen.

Data collected from a number of patient safety reporting programs indicate that between 2% and 35% of prescription errors are linked to look alike, sound alike drug name similarities.

There is a concern that mergers and acquisitions in the pharmacy space will lead to decreased competition and loose agreements between companies that will not drive significant outcomes.

Study suggests benzalkonium chloride, a preservative that has been used in ophthalmology since the 1940s, may be toxic to ocular structures.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The HIV pandemic will likely continue to be a global challenge for the foreseeable future.

Mapping iron concentration in certain regions of the brain may help predict multiple sclerosis progression risk.

Approval for tafenoquine was granted based on the efficacy and safety data gleaned from a comprehensive global clinical development program for P vivax prevention of relapse,

He is recognized in the field of social and administrative pharmacy by the American Association of College of Pharmacy at its annual meeting in Boston, Massachusetts.

All week, Pharmacy Times Editor in Chief Troy Trygstad will be providing updates on this website about his ride across Iowa with the IPA.

All week, Pharmacy Times Editor in Chief Troy Trygstad will be providing updates on this website about his ride across Iowa with the IPA.

The approval of ivosidenib fills an unmet need for patients with relapsed or refractory acute myeloid leukemia who have an IDH1 genetic mutation.

Survivors of cancer in adolescence and young adulthood may be at higher risk for endocrine diseases, such as thyroid disease, testicular dysfunction, and diabetes.

Gene-editing technology could lead to new targeted therapies and help clinicians catch developing cancers before they metastasize.

Genentech announced that the FDA has granted Breakthrough Therapy Designation to atezolizumab (Tecentriq) in combination with bevacizumab (Avastin) as a first-line treatment for patients with the most common form of liver cancer.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.